1. Home
  2. ZEO vs UBX Comparison

ZEO vs UBX Comparison

Compare ZEO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • UBX
  • Stock Information
  • Founded
  • ZEO 2005
  • UBX 2009
  • Country
  • ZEO United States
  • UBX United States
  • Employees
  • ZEO N/A
  • UBX N/A
  • Industry
  • ZEO
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • UBX Health Care
  • Exchange
  • ZEO NYSE
  • UBX Nasdaq
  • Market Cap
  • ZEO 31.6M
  • UBX 38.6M
  • IPO Year
  • ZEO N/A
  • UBX 2018
  • Fundamental
  • Price
  • ZEO $2.16
  • UBX $2.19
  • Analyst Decision
  • ZEO
  • UBX Strong Buy
  • Analyst Count
  • ZEO 0
  • UBX 2
  • Target Price
  • ZEO N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • ZEO 1.8M
  • UBX 333.6K
  • Earning Date
  • ZEO 03-18-2025
  • UBX 11-04-2024
  • Dividend Yield
  • ZEO N/A
  • UBX N/A
  • EPS Growth
  • ZEO N/A
  • UBX N/A
  • EPS
  • ZEO N/A
  • UBX N/A
  • Revenue
  • ZEO $77,582,314.00
  • UBX N/A
  • Revenue This Year
  • ZEO N/A
  • UBX N/A
  • Revenue Next Year
  • ZEO N/A
  • UBX $33.62
  • P/E Ratio
  • ZEO N/A
  • UBX N/A
  • Revenue Growth
  • ZEO N/A
  • UBX N/A
  • 52 Week Low
  • ZEO $1.05
  • UBX $0.94
  • 52 Week High
  • ZEO $11.60
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 43.33
  • UBX 58.41
  • Support Level
  • ZEO $2.04
  • UBX $1.81
  • Resistance Level
  • ZEO $2.86
  • UBX $2.39
  • Average True Range (ATR)
  • ZEO 0.24
  • UBX 0.24
  • MACD
  • ZEO -0.07
  • UBX -0.05
  • Stochastic Oscillator
  • ZEO 14.63
  • UBX 59.38

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: